ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disparities"

  • Abstract Number: 1021 • ACR Convergence 2023

    Racial Disparities Between Black and White Patients in Joint Replacement Surgery: A Systematic Review

    Max Krall1, Samuel Good1, Collin Brantner2, Diyu Pearce-Fisher2, Susan Goodman2, Michael Parks2, Peter Sculco2, Cynthia Kahlenberg2, Ajay Premkumar2, Michelle Demetres3 and John FitzGerald1, 1University of California Los Angeles, Los Angeles, CA, 2Hospital for Special Surgery, New York, NY, 3Weill Cornell Medicine, New York, NY

    Background/Purpose: Despite the documented efficacy of joint replacement surgery (JRS) for the management of refractory hip or knee osteoarthritis (OA), multiple studies have documented lower…
  • Abstract Number: 1684 • ACR Convergence 2023

    The Impact of Pregnancy Timing on Outcomes in SLE

    Catherine Sims1, Amanda Eudy2, Ceshae Harding1, Cuoghi Edens3, Mehret Birru Talabi4, Rosalind Ramsey-Goldman5, Laura Neil1 and Megan Clowse6, 1Duke University, Durham, NC, 2Duke University, Raleigh, NC, 3University of Chicago, Chicago, IL, 4University of Pittsburgh, Pittsburgh, PA, 5Northwestern University, Chicago, IL, 6Duke University, Chapel Hill, NC

    Background/Purpose: To minimize risk of poor pregnancy outcomes, the ACR Reproductive Health Guideline recommends women conceive when SLE is well controlled and treated with pregnancy-compatible…
  • Abstract Number: 0191 • ACR Convergence 2023

    Reproductive Health Discussions Between Rheumatology Providers and Systemic Lupus Erythematosus Patients: A Survey of English and Spanish-Speaking Patients

    Meredith Xepoleas1, Martha Delgado2, Jack Rodman3, Julia Simard4, Sandy Lee5 and Leanna Wise6, 1Keck School of Medicine of University of Southern California, Los Angeles, CA, 2LAC+USC/Keck School of Medicine, Los Angeles, CA, 3University of Southern California, Los Angeles, CA, 4Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, 5University of Southern California, Walnut, CA, 6LAC+USC/Keck Medicine of USC, Pasadena, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) primarily affects women of childbearing age, with a higher burden in non-Caucasian populations. Due to the increased risk of adverse…
  • Abstract Number: 1022 • ACR Convergence 2023

    Lower Rates of Statin Therapy Initiation in Dermatomyositis/Polymyositis vs. Rheumatoid Arthritis Patients with Hyperlipidemia: A Multicenter USA-Based Study (2018-2023)

    Joseph Fares1, ross Summer1 and Giorgos Loizidis2, 1The Jane and Leonard Korman Respiratory Institute, Thomas Jefferson University Hospital, Philadelphia, PA, 2Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, PA

    Background/Purpose: Despite the proven cardioprotective benefits of statin therapy in RA, concern for statin-associated muscle symptoms (SAMS) might deter clinicians from prescribing them to DM/PM…
  • Abstract Number: 1817 • ACR Convergence 2023

    Geographic Variability of Inflammatory Bowel Disease Related Mortality, 1999-2019; CDC WONDER

    Saleha Aziz1, Anum Akhlaq1, Sana Gurz2 and Yousaf Zafar1, 1University of Mississippi Medical Center, Jackson, MS, 2University of Nevada, Las Vegas, NV

    Background/Purpose: The United States makes a significant contribution to Inflammatory Bowel Disease (IBD) related disease burden worldwide. However, data on geographic variability of IBD related…
  • Abstract Number: 0194 • ACR Convergence 2023

    Reproductive Health Conversations with a Primarily Hispanic Systemic Lupus Erythematosus Population: Influences and Barriers

    Zarmeen Zaheer1, Martha Delgado2, Jack Rodman3, Julia Simard4, Sandy Lee5 and Leanna Wise6, 1Huntington Health, Tampa, FL, 2LAC+USC/Keck School of Medicine, Los Angeles, CA, 3University of Southern California, Los Angeles, CA, 4Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, 5University of Southern California, Walnut, CA, 6LAC+USC/Keck Medicine of USC, Pasadena, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease most commonly seen in women of childbearing age, with a greater burden in non-Caucasian populations. The…
  • Abstract Number: 1024 • ACR Convergence 2023

    Relationship Between Race and Ethnicity, Time to Diagnosis, and Disease Activity for Children with Juvenile Idiopathic Arthritis in the CARRA Registry

    Sarah McGuire1, Tania Atanassova2, Joanna Madej2, Manuel Jimenez2, Daniel Horton1 and for the CARRA TMJ Arthritis Workgroup3, 1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 2Rutgers, Robert Wood Johnson Medical School, New Brunswick, NJ, 3Childhood Arthritis and Rheumatology Research Alliance, Washington, DC

    Background/Purpose: Compared to non-Hispanic White children, Black children diagnosed with juvenile idiopathic arthritis (JIA) have more severe disease at diagnosis and worse outcomes, such as…
  • Abstract Number: 1841 • ACR Convergence 2023

    Clinical Trial Perceptions Among Male Patients with Systemic Lupus Erythematosus (SLE): Georgians Organized Against Lupus (GOAL) Cohort

    Hilton Mozee1, Charmayne Dunlop-Thomas1, Gaobin Bao1, Kim Schofield2, Jessica Williams3 and S. Sam Lim1, 1Emory University, Atlanta, GA, 2Georgia State Rep. HD 63, Atlanta, GA, 3Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Minority patients are disproportionately affected by SLE. Yet, they are underrepresented in SLE clinical trials compared to White patients. Specifically, patients that identify as…
  • Abstract Number: 0195 • ACR Convergence 2023

    Assessing Cardiovascular Risk in Black and Latino Patients with Systemic Lupus Erythematosus

    Glorielly Gonzalez1, Zerai Manna2, Alice Fike3, Jun Chu2, sarfaraz Hasni2 and Brian Dizon1, 1National Institute of Arthritis and Musculoskelatal and Skin Diseases, Bethesda, MD, 2Lupus Clinical Trials Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD

    Background/Purpose: Cardiovascular disease (CVD) is a major cause of mortality among patients with systemic autoimmune disease. Patients with systemic lupus erythematosus (SLE) exhibit accelerated cardiovascular…
  • Abstract Number: 1025 • ACR Convergence 2023

    Embedding Treat to Target Principles in Rheumatoid Arthritis Patient Education in Routine Care of Ethnic Minority Patients

    Sharon Dowell1, Mercedes Quinones2, Tahereh Jamshidi3, Ilona Jileaeva4, Oshoze Kadiri4 and Gail Kerr5, 1NEA Baptist Memorial Hospital, Jonesboro, AR, 2Washington DC VA Medical Center, Bethesda, MD, 3Howard University Hospital, Bethesda, MD, 4Howard University, Washington, DC, 5Washington DC VAMC/Georgetown and Howard Universities, Washington, DC

    Background/Purpose: A successful treat to target (T2T) strategy in ethnic minority (EM) patients with rheumatoid arthritis (RA) could improve patient outcomes and help reduce healthcare…
  • Abstract Number: 1859 • ACR Convergence 2023

    Examining Hydroxychloroquine Prescribing and SLE Damage in a Statewide Lupus Cohort

    Jenna Cormier1, Bryn Sutherland1, Yiran Jiang2, David Gazeley3, Jonathan Katz4, Shalvi Parikh4, Carlos Torres5, Eden Charles5, Ang Yu6, Felix Elwert6 and Christie M. Bartels7, 1Medical College of Wisconsin, Milwaukee, WI, 2Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, 3Medical College of Wisconsin, Wauwatosa, WI, 4Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 5University of Wisconsin School of Medicine and Public Health, Madison, WI, 6Department of Sociology, University of Wisconsin, Madison, WI, 7University of Wisconsin, School of Medicine and Public Health, Madison, WI

    Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous disease that disproportionately affects women, racially and ethnically minoritized populations, and people of lower socioeconomic status (SES).…
  • Abstract Number: 0151 • ACR Convergence 2023

    Arthritis: A Wealth Gap

    Risha Fayyaz1 and Anum Akhlaq2, 1University of Mississippi Medical Center, Flowood, MS, 2University of Mississippi Medical Center, Jackson, MS

    Background/Purpose: Lower socioeconomic status (SES) has been associated with worse health outcomes . Family income is a key component of SES. This study aimed to…
  • Abstract Number: 0646 • ACR Convergence 2023

    Racial Variability in Immune Responses Only Partially Explains Differential Systemic Sclerosis Disease Severity

    Kamini Kuchinad1, Ji Soo Kim1, Adrianne Woods1, Gwen Leatherman1, Laura Gutierrez2, Maureen Mayes3, Robyn Domsic4, Paula Ramos5, Richard Silver5, John Varga6, Lesley Ann Saketkoo7, Suzanne Kafaja8, Victoria Shanmugam9, Jessica Gordon10, Lorinda Chung11, Elana Bernstein12, Pravitt Gourh13, Francesco Boin14, Daniel Kastner15, Scott Zeger16, Livia Casciola-Rosen1, Fred Wigley1 and Ami Shah17, 1Department of Rheumatology, Johns Hopkins Medicine, Baltimore, MD, 2Johns Hopkins Medicine, Baltimore, MD, 3Division of Rheumatology, University of Texas McGovern Medical School, Houston, TX, 4University of Pittsburgh, Pittsburgh, PA, 5Medical University of South Carolina, Charleston, SC, 6University of Michigan, Ann Arbor, MI, 7University Medical Center - Comprehensive Pulmonary Hypertension Center and ILD Clinic Programs // New Orleans Scleroderma and Sarcoidosis Patient Care & Research Centeris, New Orleans, LA, 8UCLA Department of Medicine, Division of Rheumatology, Los Angeles, CA, 9Victoria Shanmugam, MD, Great Falls, VA, 10Hospital for Special Surgery, New York, NY, 11Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Woodside, CA, 12Columbia University, New York, NY, 13National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 14Cedars-Sinai Medical Center, Los Angeles, CA, 15National Human Genome Research Institute, Bethesda, MD, 16Johns Hopkins University, Baltimore, MD, 17Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Ellicott City, MD

    Background/Purpose: Individuals with self-identified Black race have a higher incidence of systemic sclerosis (SSc), develop SSc at a younger age, and have a more severe…
  • Abstract Number: 1026 • ACR Convergence 2023

    Patients’ Barriers to Total Joint Arthroplasty: Associations with the Orthopedic Consultation

    Insa Mannstadt1, J. Alex Gibbons2, Troy Amen1, Mangala Rajan3, Sarah Young4, Michael Parks1, Mark Figgie1, Anne Bass5, Linda Russell1, Bella Mehta5, iris Navarro-Millán1 and Susan Goodman1, 1Hospital for Special Surgery, New York, NY, 2Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 3Weill Cornell Medicine, New York, NY, 4Binghamton University, Binghamton, NY, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: While racial/ethnic disparities in total joint arthroplasty (TJA) utilization are well-documented, the impact of orthopedic specialists on patients' perceptions of TJA is poorly understood.…
  • Abstract Number: 1903 • ACR Convergence 2023

    Assessing Disparities Through Missing Race and Ethnicity Data: Results from a Juvenile Arthritis Registry

    Katelyn Banschbach1, Jade Singleton2, Esi Morgan2 and Xing Wang3, 1University of Washington, Seattle, WA, 2Seattle Children's Hospital, Seattle, WA, 3Biostatistics Epidemiology and Analytics in Research (BEAR), Seattle Children’s Research Institute, Seattle, WA

    Background/Purpose: Research databases are missing 25-50% of race and ethnicity, typically related to Black and Hispanic data.1,2The absence of this data can lead to inaccurate…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology